One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The documents were needed to verify testing and manufacturing practices at Granules, a company in Telangana, India, that supplies generic medications to the U.S., officials say. More pharmaceutical ...

Last week, WHO said it granted its first authorisation for use of a vaccine against mpox in adults, calling it an important ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

The vaccination campaign against mpox in the Democratic Republic of Congo is to begin on October 2, the public health ...

Saad B. Omer Mpox (formerly known as monkeypox) is back in the news. As of early September, the World Health Organization has ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

Rwanda has initiated a vaccination campaign against mpox with 1,000 doses from Nigeria. The campaign, targeting high-risk ...

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as ...

The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company ...